Top Sell
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.74 | - | - |
| Pacific Biosciences of California Inc. | 10 | 4 | 1 | 0 | €1.24 | €9.20 | 639.228% |
| Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | €0.32 | €4.61 | 1330.502% |
| Syros Pharmaceuticals Inc. | 9 | 1 | 3 | 0 | €1.51 | €12.01 | 695.066% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.69 | €5.49 | 691.580% |
| QuidelOrtho Corp. | 8 | 2 | 2 | 0 | €39.60 | €63.07 | 59.268% |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €45.21 | €67.64 | 49.627% |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.51 | €5.47 | 976.366% |
| Gritstone Oncology Inc | 6 | 1 | 2 | 0 | €0.43 | €3.68 | 747.924% |
| Cellectar BioSciences Inc. | 5 | 4 | 0 | 0 | €1.98 | €11.09 | 460.182% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.63 | €21.44 | 180.827% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €58.02 | - | - |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Glycomimetics Inc. | 3 | 6 | 0 | 3 | €0.15 | €9.13 | 5909.605% |
| Owens & Minor Inc. | 3 | 3 | 1 | 1 | €14.30 | €20.11 | 40.613% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Moleculin Biotech Inc | 3 | 25 | 0 | 2 | €0.41 | €18.42 | 4393.659% |
| Integra LifeSciences Holdings Corp | 3 | 6 | 0 | 2 | €18.60 | €31.62 | 69.975% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.26 | €10.66 | 746.167% |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.09 | €5.00 | 139.808% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 87.849% |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.06 | €50.00 | 4603.669% |